Annual Accounts Receivable
$1.53 M
-$3.13 M-67.26%
December 31, 2023
Summary
- As of February 22, 2025, XLO annual accounts receivable is $1.53 million, with the most recent change of -$3.13 million (-67.26%) on December 31, 2023.
- During the last 3 years, XLO annual accounts receivable has fallen by -$527.20 thousand (-25.68%).
- XLO annual accounts receivable is now -67.26% below its all-time high of $4.66 million, reached on December 31, 2022.
Performance
XLO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XLO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.3% | - |
| 3 y3 years | -25.7% | - |
| 5 y5 years | +411.9% | - |
XLO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.3% | +440.7% | ||
| 5 y | 5-year | -67.3% | +440.7% | ||
| alltime | all time | -67.3% | +2321.3% |
Xilio Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $1.53 M(-67.3%) | - |
| Dec 2022 | $4.66 M(+1551.4%) | - |
| Dec 2021 | $282.10 K(-86.3%) | - |
| Dec 2020 | $2.05 M(+386.3%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $422.10 K(+41.6%) | - |
| Dec 2018 | $298.00 K(+234.8%) | - |
| Dec 2017 | $89.00 K(+41.3%) | - |
| Dec 2016 | $63.00 K | - |
FAQ
- What is Xilio Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Xilio Therapeutics?
- What is Xilio Therapeutics annual accounts receivable year-on-year change?
What is Xilio Therapeutics annual accounts receivable?
The current annual accounts receivable of XLO is $1.53 M
What is the all time high annual accounts receivable for Xilio Therapeutics?
Xilio Therapeutics all-time high annual accounts receivable is $4.66 M
What is Xilio Therapeutics annual accounts receivable year-on-year change?
Over the past year, XLO annual accounts receivable has changed by -$3.13 M (-67.26%)